Hasbro, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Hasbro, Inc. trades at $97.48 (market cap $13.69B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Hasbro, Inc. is far larger — about 174.3× Inovio Pharmaceuticals Inc's market cap, and Hasbro, Inc. pays a 2.89% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| HAS | INO | |
|---|---|---|
Market Cap | $13.69B | $78.55M |
Sector | Consumer Cyclical | Health |
52-Week High | $105.88 | $2.87 |
52-Week Low | $70.95 | $0.66 |
Enterprise Value | $15.88B | $49.56M |
Dividend Yield | 2.89% | — |
Trailing returns across standard periods
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →